Exelixis
EXEL
#1622
Rank
S$17.11 B
Marketcap
S$68.11
Share price
0.76%
Change (1 day)
25.42%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company